Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-scid chimeras

Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ (1997)
J. Clin. Invest. 99(12): 2842-2850.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
J. Clin. Invest.
Band
99
Zeitschriftennummer
12
Seite
2842-2850
ISSN
PUB-ID

Zitieren

Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-scid chimeras. J. Clin. Invest. 1997;99(12):2842-2850.
Brack, A., Rittner, H. L., Younge, B. R., Kaltschmidt, C., Weyand, C. M., & Goronzy, J. J. (1997). Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-scid chimeras. J. Clin. Invest., 99(12), 2842-2850. doi:10.1172/JCI119477
Brack, A., Rittner, H. L., Younge, B. R., Kaltschmidt, C., Weyand, C. M., and Goronzy, J. J. (1997). Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-scid chimeras. J. Clin. Invest. 99, 2842-2850.
Brack, A., et al., 1997. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-scid chimeras. J. Clin. Invest., 99(12), p 2842-2850.
A. Brack, et al., “Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-scid chimeras”, J. Clin. Invest., vol. 99, 1997, pp. 2842-2850.
Brack, A., Rittner, H.L., Younge, B.R., Kaltschmidt, C., Weyand, C.M., Goronzy, J.J.: Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-scid chimeras. J. Clin. Invest. 99, 2842-2850 (1997).
Brack, A., Rittner, H.L., Younge, B.R., Kaltschmidt, Christian, Weyand, C.M., and Goronzy, J.J. “Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-scid chimeras”. J. Clin. Invest. 99.12 (1997): 2842-2850.

68 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.
Slart RHJA, Writing group, Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, Members of Committees, SNMMI Cardiovascular, Members of Council, PET Interest Group, Members of ASNC, EANM Committee Coordinator., Eur J Nucl Med Mol Imaging 45(7), 2018
PMID: 29637252
Tocilizumab for the treatment of giant cell arteritis.
Schirmer M, Muratore F, Salvarani C., Expert Rev Clin Immunol 14(5), 2018
PMID: 29676602
The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review.
Yamauchi R, Araki T, Mitsuyama K, Tokito T, Ishii H, Yoshioka S, Kuwaki K, Mori A, Yoshimura T, Tsuruta O, Torimura T., BMC Gastroenterol 18(1), 2018
PMID: 30170560
New insights into the pathogenesis of giant cell arteritis.
Ciccia F, Rizzo A, Ferrante A, Guggino G, Croci S, Cavazza A, Salvarani C, Triolo G., Autoimmun Rev 16(7), 2017
PMID: 28479485
Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study.
Labarca C, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Warrington KJ., Rheumatology (Oxford) 55(2), 2016
PMID: 26385368
Endothelial Response to Glucocorticoids in Inflammatory Diseases.
Zielińska KA, Van Moortel L, Opdenakker G, De Bosscher K, Van den Steen PE., Front Immunol 7(), 2016
PMID: 28018358
Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritis.
Chen H, Zheng D, Ambadapadi S, Davids J, Ryden S, Samy H, Bartee M, Sobel E, Dai E, Liu L, Macaulay C, Yachnis A, Weyand C, Thoburn R, Lucas A., PLoS One 10(2), 2015
PMID: 25658487
Giant Cell Arteritis: Beyond Corticosteroids.
Steel L, Khan A, Dasgupta B., Drugs Aging 32(8), 2015
PMID: 26239828
Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis.
Corbera-Bellalta M, García-Martínez A, Lozano E, Planas-Rigol E, Tavera-Bahillo I, Alba MA, Prieto-González S, Butjosa M, Espígol-Frigolé G, Hernández-Rodríguez J, Fernández PL, Roux-Lombard P, Dayer JM, Rahman MU, Cid MC., Ann Rheum Dis 73(3), 2014
PMID: 23625984
Biomarkers in vasculitis.
Monach PA., Curr Opin Rheumatol 26(1), 2014
PMID: 24257367
Design of the tocilizumab in giant cell arteritis trial.
Unizony SH, Dasgupta B, Fisheleva E, Rowell L, Schett G, Spiera R, Zwerina J, Harari O, Stone JH., Int J Rheumatol 2013(), 2013
PMID: 23653652
Immune mechanisms in medium and large-vessel vasculitis.
Weyand CM, Goronzy JJ., Nat Rev Rheumatol 9(12), 2013
PMID: 24189842
Cartilage destruction in granulomatosis with polyangiitis (Wegener's granulomatosis) is mediated by human fibroblasts after transplantation into immunodeficient mice.
Kesel N, Köhler D, Herich L, Laudien M, Holl-Ulrich K, Jüngel A, Neidhart M, Gay S, Gay RE, Csernok E, Lamprecht P, Gross WL, Schumacher U, Ullrich S., Am J Pathol 180(5), 2012
PMID: 22449947
Transient opening of the perineurial barrier for analgesic drug delivery.
Hackel D, Krug SM, Sauer RS, Mousa SA, Böcker A, Pflücke D, Wrede EJ, Kistner K, Hoffmann T, Niedermirtl B, Sommer C, Bloch L, Huber O, Blasig IE, Amasheh S, Reeh PW, Fromm M, Brack A, Rittner HL., Proc Natl Acad Sci U S A 109(29), 2012
PMID: 22733753
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis.
Weyand CM, Younge BR, Goronzy JJ., Curr Opin Rheumatol 23(1), 2011
PMID: 20827207
Th17 and Th1 T-cell responses in giant cell arteritis.
Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM., Circulation 121(7), 2010
PMID: 20142449
Recent advances in the immunopathology of giant cell arteritis.
Chang KK, Rizzo JF., Int Ophthalmol Clin 49(1), 2009
PMID: 19125069
[Pathogenesis of medium- and large-vessel vasculitis].
Weyand CM, Goronzy JJ., Z Rheumatol 68(2), 2009
PMID: 19224227
Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases.
Zhou L, Luneau K, Weyand CM, Biousse V, Newman NJ, Grossniklaus HE., Ophthalmology 116(8), 2009
PMID: 19500846
Vascular damage in giant cell arteritis.
Piggott K, Biousse V, Newman NJ, Goronzy JJ, Weyand CM., Autoimmunity 42(7), 2009
PMID: 19657775
Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation.
Han JW, Shimada K, Ma-Krupa W, Johnson TL, Nerem RM, Goronzy JJ, Weyand CM., Circ Res 102(5), 2008
PMID: 18202318
Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment.
Martinez-Taboada VM, Alvarez L, RuizSoto M, Marin-Vidalled MJ, Lopez-Hoyos M., Cytokine 44(2), 2008
PMID: 18986814
Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2.
Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, Vergani D., Hepatology 46(2), 2007
PMID: 17559153
Five clinical conundrums in the management of giant cell arteritis.
Cid MC, García-Martínez A, Lozano E, Espígol-Frigolé G, Hernández-Rodríguez J., Rheum Dis Clin North Am 33(4), 2007
PMID: 18037119
Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA, Martin J., Drugs Aging 23(8), 2006
PMID: 16964987
Sustained spontaneous clinical remission in giant cell arteritis: report of two cases with long-term followup.
Hernández-Rodríguez J, García-Martínez A, Espígol-Frigolé G, Grau JM, Collado A, Cid MC., Arthritis Rheum 55(1), 2006
PMID: 16463393
Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.
Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H., Arthritis Rheum 55(1), 2006
PMID: 16463425
Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain.
Rittner HL, Mousa SA, Labuz D, Beschmann K, Schäfer M, Stein C, Brack A., J Leukoc Biol 79(5), 2006
PMID: 16522746
Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation.
Puehler W, Rittner HL, Mousa SA, Brack A, Krause H, Stein C, Schäfer M., Neuroscience 141(2), 2006
PMID: 16782281
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ., Arthritis Rheum 54(10), 2006
PMID: 17009270
[Glucocorticoids: importance in the treatment of vasculitis].
Aries PM, Hellmich B, Gross WL., Z Rheumatol 64(3), 2005
PMID: 15868332
Effects of prednisolone treatment on cytokine expression in patients with leprosy type 1 reactions.
Andersson AK, Chaduvula M, Atkinson SE, Khanolkar-Young S, Jain S, Suneetha L, Suneetha S, Lockwood DN., Infect Immun 73(6), 2005
PMID: 15908402
[Simple Horton's syndrome: modalities of treatment].
Agard C, Barrier JH., Presse Med 33(1), 2004
PMID: 15026724
[Complicated Horton's syndrome: therapeutic modalities].
Agard C, Barrier JH., Presse Med 33(1), 2004
PMID: 15026725
Giant cell arteritis: strategies in diagnosis and treatment.
Nordborg E, Nordborg C., Curr Opin Rheumatol 16(1), 2004
PMID: 14673385
Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain.
Brack A, Rittner HL, Machelska H, Beschmann K, Sitte N, Schäfer M, Stein C., Anesthesiology 100(1), 2004
PMID: 14695736
Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis.
Ma-Krupa W, Jeon MS, Spoerl S, Tedder TF, Goronzy JJ, Weyand CM., J Exp Med 199(2), 2004
PMID: 14734523
Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction.
Puehler W, Zöllner C, Brack A, Shaqura MA, Krause H, Schäfer M, Stein C., Neuroscience 129(2), 2004
PMID: 15501604
Large-vessel vasculitis.
Seo P, Stone JH., Arthritis Rheum 51(1), 2004
PMID: 14872466
Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis.
García-Martínez A, Hernández-Rodríguez J, Grau JM, Cid MC., Arthritis Rheum 51(4), 2004
PMID: 15334444
Giant cell arteritis: managing the ophthalmic medical emergency.
Danesh-Meyer H., Clin Exp Ophthalmol 31(3), 2003
PMID: 12786764
Medium- and large-vessel vasculitis.
Weyand CM, Goronzy JJ., N Engl J Med 349(2), 2003
PMID: 12853590
Therapeutic effects of acetylsalicylic acid in giant cell arteritis.
Weyand CM, Kaiser M, Yang H, Younge B, Goronzy JJ., Arthritis Rheum 46(2), 2002
PMID: 11840449
Transcriptional and post-transcriptional mechanisms of glucocorticoid antiproliferative effects.
Almawi WY, Abou Jaoude MM, Li XC., Hematol Oncol 20(1), 2002
PMID: 11921014
CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis.
Kang YM, Zhang X, Wagner UG, Yang H, Beckenbaugh RD, Kurtin PJ, Goronzy JJ, Weyand CM., J Exp Med 195(10), 2002
PMID: 12021312
Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries.
Borkowski A, Younge BR, Szweda L, Mock B, Björnsson J, Moeller K, Goronzy JJ, Weyand CM., Am J Pathol 161(1), 2002
PMID: 12107096
Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis.
Krupa WM, Dewan M, Jeon MS, Kurtin PJ, Younge BR, Goronzy JJ, Weyand CM., Am J Pathol 161(5), 2002
PMID: 12414528
Current neuro-ophthalmic therapies.
Movsas TZ, Liu GT, Galetta SL, Balcer LJ, Volpe NJ., Neurol Clin 19(1), 2001
PMID: 11471762
Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits.
Poon M, Gertz SD, Fallon JT, Wiegman P, Berman JW, Sarembock IJ, Taubman MB., Atherosclerosis 155(2), 2001
PMID: 11254907
New approaches to treatment in systemic vasculitis: biological therapies.
Levine SM, Stone JH., Best Pract Res Clin Rheumatol 15(2), 2001
PMID: 11469824
Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions.
Cid MC, Cebrián M, Font C, Coll-Vinent B, Hernández-Rodríguez J, Esparza J, Urbano-Márquez A, Grau JM., Arthritis Rheum 43(1), 2000
PMID: 10643715
Are animal models of vasculitis suitable tools?
Specks U., Curr Opin Rheumatol 12(1), 2000
PMID: 10647949
Pathogenic principles in giant cell arteritis.
Weyand CM, Goronzy JJ., Int J Cardiol 75 Suppl 1(), 2000
PMID: 10980331
Disease pattern in cranial and large-vessel giant cell arteritis.
Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM., Arthritis Rheum 42(2), 1999
PMID: 10025926
Induction of pituitary cytokine transcripts by peripheral lipopolysaccharide.
Whiteside MB, Quan N, Herkenharn M., J Neuroendocrinol 11(2), 1999
PMID: 10048466
Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.
Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM., J Clin Invest 103(7), 1999
PMID: 10194473
Tissue-destructive macrophages in giant cell arteritis.
Rittner HL, Kaiser M, Brack A, Szweda LI, Goronzy JJ, Weyand CM., Circ Res 84(9), 1999
PMID: 10325242
Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.
Kaiser M, Younge B, Björnsson J, Goronzy JJ, Weyand CM., Am J Pathol 155(3), 1999
PMID: 10487834
Giant cell arteritis.
Hunder GG., Lupus 7(4), 1998
PMID: 9643316
Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis.
Kaiser M, Weyand CM, Björnsson J, Goronzy JJ., Arthritis Rheum 41(4), 1998
PMID: 9550471
Central nervous system vasculitis.
Moore PM., Curr Opin Neurol 11(3), 1998
PMID: 9642543
Multiplicity of glucocorticoid action in inhibiting allograft rejection.
Almawi WY, Hess DA, Rieder MJ., Cell Transplant 7(6), 1998
PMID: 9853580
Sonography in giant-cell arteritis.
Hunder GG, Weyand CM., N Engl J Med 337(19), 1997
PMID: 9358135
Tissue cytokine patterns distinguish variants of rheumatoid synovitis.
Klimiuk PA, Goronzy JJ, Björ nsson J, Beckenbaugh RD, Weyand CM., Am J Pathol 151(5), 1997
PMID: 9358757

31 References

Daten bereitgestellt von Europe PubMed Central.

Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study.
Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR., Ann. Intern. Med. 88(2), 1978
PMID: 626444
Disease patterns and tissue cytokine profiles in giant cell arteritis.
Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ., Arthritis Rheum. 40(1), 1997
PMID: 9008596
Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta.
Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM., J. Exp. Med. 171(1), 1990
PMID: 2295877
Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.
Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, Herrlich P., Cell 62(6), 1990
PMID: 2169351
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.
Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM., Cell 62(6), 1990
PMID: 2169353
Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes.
AyanlarBatuman O, Ferrero AP, Diaz A, Jimenez SA., J. Clin. Invest. 88(5), 1991
PMID: 1939646
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA., J. Exp. Med. 175(5), 1992
PMID: 1314883
Interleukin-6 in autoimmune disorders.
Yoshizaki K, Kuritani T, Kishimoto T., Semin. Immunol. 4(3), 1992
PMID: 1627787
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.
Barral-Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, Twardzik DR, Reed SG., Science 257(5069), 1992
PMID: 1636092
Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta.
Wahl SM, Allen JB, Costa GL, Wong HL, Dasch JR., J. Exp. Med. 177(1), 1993
PMID: 8418203
Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes.
Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE., Proc. Natl. Acad. Sci. U.S.A. 90(10), 1993
PMID: 8506302
Suppression of arthritis by an inhibitor of nitric oxide synthase.
McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM., J. Exp. Med. 178(2), 1993
PMID: 7688035
Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.
Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM., Arthritis Rheum. 36(9), 1993
PMID: 8216422
Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates.
Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE., Ann. Intern. Med. 119(12), 1993
PMID: 8239251
Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes.
Weyand CM, Schonberger J, Oppitz U, Hunder NN, Hicok KC, Goronzy JJ., J. Exp. Med. 179(3), 1994
PMID: 8113687
Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.
Weyand CM, Hicok KC, Hunder GG, Goronzy JJ., Ann. Intern. Med. 121(7), 1994
PMID: 8067646
Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice.
Lowrance JH, O'Sullivan FX, Caver TE, Waegell W, Gresham HD., J. Exp. Med. 180(5), 1994
PMID: 7964455
Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody.
Kaltschmidt C, Kaltschmidt B, Henkel T, Stockinger H, Baeuerle PA., Biol. Chem. Hoppe-Seyler 376(1), 1995
PMID: 7612189
Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells.
Batuman OA, Ferrero A, Cupp C, Jimenez SA, Khalili K., J. Immunol. 155(9), 1995
PMID: 7594600
Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.
Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr., Science 270(5234), 1995
PMID: 7569975
Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M., Science 270(5234), 1995
PMID: 7569976
Local regulation of the coronary circulation in health and disease: role of nitric oxide and endothelin.
Luscher TF, Wenzel RR, Noll G., Eur. Heart J. 16 Suppl C(), 1995
PMID: 7556273
Nitric oxide: a novel mediator of inflammation.
Clancy RM, Abramson SB., Proc. Soc. Exp. Biol. Med. 210(2), 1995
PMID: 7568290
The NF-kappa B and I kappa B proteins: new discoveries and insights.
Baldwin AS Jr., Annu. Rev. Immunol. 14(), 1996
PMID: 8717528
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB., Proc. Natl. Acad. Sci. U.S.A. 84(16), 1987
PMID: 2886992

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 9185506
PubMed | Europe PMC

Suchen in

Google Scholar